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Abstract: Retinoic acid (RA) is an important signaling molecule in the development of the
endoderm and an important molecule in protocols used to generate endodermal cell types
from stem cells. In this review, we describe the RA signaling pathway and its role in the
patterning and specification of the extra embryonic endoderm and different endodermal
organs. The formation of endoderm is an ancient evolutionary feature and RA signaling
appears to have coevolved with the vertebrate lineage. Towards that end, we describe how
RA participates in many regulatory networks required for the formation of extraembryonic
structures as well as the organs of the embryo proper.
Keywords: retinoic acid; retinoids; endoderm; embryology;
anterior-posterior axis; thyroid; lung; pancreas; extraembryonic endoderm

development;

1. Introduction
Retinoic acid (RA) signaling is one of the fundamental regulatory pathways in the development of
vertebrates with roles in the differentiation and patterning of lineages from all three germ layers [1,2]
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including the endoderm, which is the subject of this review. A significant role for RA signaling in the
development of endoderm might appear somewhat surprising because endoderm is a germ layer of all
multi-layered embryos, whereas the RA signaling system has often been described as a signaling
system that has arisen during chordate evolution [3,4]. There is now, however, evidence that homologues
of enzymes and receptors necessary for RA signaling exist in different invertebrates [5–7], but it is still
not clear as to whether or not these homologues function in an analogous manner. If in fact they have
alternate functions, then retinoic acid signaling may be an adaption that occurred during evolution and
unique to the chordates. Whatever the case, that Caenorhabditis and Drosophila do not have functional
RA receptors would indicate that a functional endoderm does not require retinoic acid signaling. In
addition, some urochordates appear to have lost the fundamental machinery necessary for RA
signaling, yet still produce a functional endoderm [8]. A lack of retinoic acid signaling does not alter
initial endoderm formation in zebrafish [9], Xenopus [10] or the initial endoderm patterning in chick [11].
That said, the endoderm in vertebrates has evolved a number of novel innovations, including the generation
of unique endoderm-derived organs and the formation of an extraembryonic endoderm. It is in the
development of these novel endoderm features that retinoic acid signaling is clearly required.
2. What is Endoderm?
Endoderm is the inner germ layer in both diploblastic and triploblastic embryos. In general, it forms
an internal epithelial tube that represents the digestive tract. This primitive feeding feature, coupled
with recent analysis of tissue-specific gene expression in diverse organisms, suggests that the
endoderm is the original germ layer [12]. In vertebrates, that tube has a series of lateral extensions,
which give rise to organs including the thyroid gland, thymus, lungs, liver, and pancreas (Figure 1).
Ectoderm, the outer germ layer of the embryo, will form the skin, nervous system and the specialized
neural crest cells. Mesoderm, the layer that comes to lie between the endoderm and mesoderm forms a
variety of organs including the cardiovascular system, muscles and kidneys. Both molecular and fate
mapping evidence suggests that the endoderm and mesoderm actually arise from a common progenitor
termed the mesendoderm [13]. Key transcription factors for mesoderm and endoderm are expressed in
the same cells in zebrafish [14,15] and Xenopus [16] and the fate map of the Caenorhabiditis embryo
shows that one blastomere gives rise to both lineages [17]. However, given the ancient origin of the
endoderm relative to mesoderm [12], it is likely that the common progenitor represents a derived
developmental strategy and, although widespread, is not universal [18].
Endoderm differentiation requires integration of multiple signaling events early in development.
Nodal, a member of the TGFβ superfamily of signaling molecules is essential for the development of
the mesendoderm [19] and varying levels of Nodal signaling are important not only in the segregation
of the endoderm from mesoderm [20], but also in patterning the extraembryonic endoderm [21,22] as
described below. Nodal signaling subsequently regulates the expression of several transcription factors
that represent a conserved network essential for differentiation of the endoderm including members of
the Forkhead, Gata, Mixer, Sox, and PouV transcription factor families [13,23,24]. Interestingly,
metabolism of maternal RA by Cyp26 enzymes is required to limit the expression of Nodal in the
mouse, thereby preventing duplication of the body axis, but it is unclear as to whether or not this RA
plays any role in mesendoderm differentiation [25]. That Wnt signaling is required for the maintenance
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of Nodal expression [26] and Nodal is in turn required for the maintenance of Wnt3 expression [27]
would indicate complex interactions are needed to regulate Nodal levels that are critical for endoderm
differentiation. Although RA signaling is required for many early developmental events, there is no
evidence that it plays a role in endodermal differentiation in vivo. This is surprising as RA is routinely
used to generate endoderm from several undifferentiated embryonal carcinoma and embryonic stem
cell lines [28–31]. Where RA does appear to play important roles is in the patterning of the endoderm
once it is differentiated and in the differentiation of specific endodermal organs.

Figure 1. Derivatives of the endoderm form along the gut tube in a precise anterior to
posterior order. The gut is first divided into broad regions of foregut, midgut, and hindgut.
Subsequently, the gut is further subdivided so that individual organ types form in a precise
order with the thyroid being the most posterior. Retinoic acid (RA) is essential for the
development of most organ primordial posterior to the thyroid with the strongest
requirement being in the dorsal anterior derivatives such as dorsal pancreas and lung. The
pancreas is formed from a dorsal and ventral bud. Retinoic acid is required for dorsal
pancreatic bud formation but not the ventral bud in most organisms.
3. Retinoic Acid Signaling
As cell signaling pathways go, that involving RA is essentially quite simple although, as with most
biological systems, it is more complicated than it first appears. Retinoic acid is a metabolite of vitamin
A and a small molecule, with a molecular weight of 300 daltons. It is highly lipophilic, enabling it to
readily pass through the plasma membrane and move to the nucleus, where it binds to heterodimers of
nuclear receptors belonging to one of two small families: the RA receptors (RARα, RARβ, and RARγ)
and the retinoid X receptors (RXRα, RXRβ, and RXRγ) [2,32]. When RA is absent, RAR/RXR
heterodimers bind specific DNA binding sites within the genome where they act to recruit repressive
complexes that inhibit transcription [33]. In the presence of RA, however, the repressive complex
bound to the receptor is exchanged for an activating complex and transcription at the target site is
promoted. Thus, the RARs are considered ligand-activated transcription factors. As the receptors are
already present on many target genes, this makes RA the limiting factor in deciding whether or not
target genes are activated.
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3.1. Generating Retinoic Acid
Vitamin A (retinol) is taken up in the maternal diet and is supplied to the egg during oogenesis. The
first step in the formation of RA is the conversion of retinol to retinaldehyde. Different members of the
alcohol dehydrogenase or retinol dehydrogenase families catalyze this oxidation step. Of these enzymes,
the most important for early embryogenesis is Rdh10. Mice lacking this enzyme have severe
developmental defects and die at about E10.5 [34–36]. The strong requirement for Rdh10 in RA signaling
is also conserved in Xenopus [37]. This step in RA synthesis is strongly regulated by a negative feedback
loop, where the addition of RA causes a down regulation in Rdh10 expression and a concomitant up
regulation of Dhrs3a, an enzyme that catalyzes the reverse reaction generating retinol from
retinaldehyde [38].
The subsequent generation and maintenance of all-trans RA levels is critical and the enzymes that
both generate and subsequently catalyze it are also subject to tightly regulated feedback loops [2,39].
Indeed, RA teratogenicity is, in part, explained by a down regulation of RA signaling caused by the
exposure to high levels of RA [40]. Several enzymes are responsible for the conversion of
retinaldehyde to all-trans RA, primarily members of the Raldh family, with each member having
unique developmental expression patterns [41]. Based on the phenotypes of mice lacking individual
genes within the Raldh family, Aldh1a2 is the main enzyme responsible for RA production during
early development. In mice, the loss of Aldh1a2 results in dramatic embryonic phenotypes with
disruptions in multiple organs and lethality at E9.5–10.5 [42–45]. Interestingly, the loss of Aldh1a1 in
mice does not result in any observable phenotype [46], while the loss of Aldh1a3 results in defects in
the ocular and nasal regions [47] as well as neuronal differentiation in the brain [48].
There are alternative mechanisms for generating RA, including one that uses β-carotene as a
substrate [49–52]. Unfortunately, the roles for these alternative pathways in development have not
been fully explored. Importantly for this review, it appears that Aldh1a2 is the sole source of RA
generation in the endoderm and the surrounding lateral plate mesoderm, at least until e9.5 in
mouse [53].
Despite the fact that RA signaling activity appears to be primarily controlled by the levels of the
ligand, the importance of catabolism is often overlooked [54]. The primary catabolic enzymes include
members of the cytochrome p450 family, specifically Cyp26A1, Cyp26B1 and Cyp26C1 [55]. Loss of
Cyp26 enzymes in zebrafish and mice results in severe phenotypes with caudal truncations, homeotic
transformations and embryonic lethality [25,56–58]. It is interesting to note many of these phenotypes
are very similar to the phenotype caused by the administration of teratogenic doses of RA [59].
3.2. Movement of Retinoic Acid
Once generated, RA moves freely between cells, an activity that made it a proposed diffusible
morphogen patterning limb development [60]. Specific cellular binding proteins exist that are thought
to solubilize RA in order to aid in its intracellular transport through the aqueous cytoplasm to the nucleus
and for facilitating its degradation by Cyp26A1. The role for the cellular retinoic acid-binding proteins
(CRABPs and CRBP) is somewhat less clear. Despite recent work suggesting that the presence of
these RA-binding proteins allows for greater fine-tuning of the RA signal [61], it is clear from the
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knockouts in mice that CRABPs and CRBP are not essential proteins [62,63]. Thus, the requirement
for these binding proteins in intercellular signaling by RA is not well understood, although a role for
CRABPs in hindbrain patterning in zebrafish, presumably through altering the dynamics of the retinoic
acid response, has been demonstrated [61].
Movement across a membrane appears to be facilitated in some cell contexts by Stra6, a membrane
bound protein that can interact with retinol binding protein, which binds retinol in the serum. The loss
of Stra6 in the mouse has only a modest effect on the levels of RA signaling in most tissues, with the
exception of the eye [64]. Here, the presence of Stra6 is necessary for both normal morphology and a
proper visual response [65]. It is interesting to note that human mutations in STRA6 are associated with
multiple developmental defects including, in some patients, lung hypoplasia [66,67].
3.3. Interaction with DNA
RARs bind to DNA as a heterodimer with an RXR. As both receptors have essentially the same
DNA recognition site (RGKTCA), a canonical retinoic acid response element (RARE) is usually two
direct repeats of the recognition sequence, separated by a spacer region of variable length [68]. The use
of chromatin immunoprecipitation (ChIP), however, with antibodies against RARs has demonstrated a
much greater diversity of RAREs than previously appreciated, including direct repeats with no
spacer [69]. There is also evidence that inverted repeats with no spacer can also the target for
RARs [69]. ChIP results also suggest that RA bound to receptors already on the promoter of target genes
may not be representative of all of the potential targets. For instance, RAR-DNA interactions appear after
the addition of RA [70], suggesting that receptors lacking RA are not necessarily bound to DNA or that
unbound receptors do not immunoprecipitate well. In addition, RAR phosphorylation has demonstrated
the importance in regulating the activity of the receptor [71,72]. Specifically, deleting an RARγ2 in
mouse ES cells and replacing it with the same receptor, but with mutated phospho-acceptor sites,
demonstrated that phosphorylation was necessary for differentiation of these cells into neurons.
In addition to the targeting based on binding to known RAREs, the specificity of binding is also
regulated by interactions of other transcription factors and the epigenetic landscape around the RARE.
Indeed, the cell specificity of the response to RA signaling is probably due to interactions with different
regulatory proteins [73,74]. For example, fibroblasts and embryonic stem cells show clear differences in
binding sites for RARs [73] as do embryonic stem cells and differentiated neurons [70]. Work in breast
cancer cell lines has identified FoxA1 and GATA3 as potential tissue-specific co-regulators [75] and
given the complexity of RA signaling in different cell types. The differing epigenetic signature of
different cell types will also regulate where RARs may bind or regulate their activity levels [76].
Defining these cell-specific mechanisms for defining RA targets in different cells will be an important
avenue for future research.
4. The Role of Retinoic Acid in Anterior-Posterior Patterning of the Endoderm
The initial steps in anterior-posterior patterning of the endoderm is started by a combination of Wnt,
Fgf, and BMP signaling at the posterior end of the endoderm [13]. Wnt antagonism at the anterior end
counteracts this signal, setting up an initial broad pattern of transcription factor expression. Hhex and
Sox2 expression marks the presumptive foregut, Pdx1 the midgut, and Cdx expression the hindgut [13].
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Although the treatment of embryos with RA or RA antagonists near gastrulation can alter the
boundaries of early endoderm, as shown by changes to pancreatic differentiation [9,10,77], it is not
clear as to what the RA is affecting at these early stages.
Studies of RA signaling in endoderm development has largely concentrated on its role in the
differentiation and growth of particular endodermal organs and have demonstrated that RA is essential
for the normal development of almost all of them. However, before organogenesis, RA plays an
essential role in the anterior-posterior patterning of the endoderm, and it is clear that the requirement for
RA for different organ systems differ depending approximately on their position along this axis [11].
However, RA does not act in a strictly anterior-posterior gradient. Based on the expression pattern of
Aldh1a2 or of reporters of RA signaling, the highest regions of RA signaling appears to be the middle of
the embryo, with the head and tail regions having little or no signaling activity (Figure 2). In Xenopus,
this signaling also appears to be higher on the dorsal side [78,79]. This dorsal, middle region corresponds
approximately to where more anterior organs, such as the dorsal pancreatic bud and lung that absolutely
require RA are positioned. This requirement is not as crucial for the more posterior organs such as liver
and ventral pancreatic bud. Interestingly, the thyroid, which is the most anterior organ derivative, must
develop in the absence of RA [11,80]. Thus, the degree of requirement for RA in specific endodermal
organs would appear to correspond to the levels of RA at a particular point along the anterior-posterior
axis. Whether or not RA is in a gradient along that axis is tenuous, but the sensitivity of different regions
to antagonists and the non-overlapping expression of Aldh1a2 and Cyp26 suggest that a graded
distribution is likely [11]. What is clear is that RA generates anterior-posterior patterning in the
developing neural tube [81,82] and in the mesoderm [83].

Figure 2. Retinoic acid activity varies along the anterior-posterior axis but does not form a
precise gradient along the entire axis. Using either Aldh1a2 expression or reporters of RA
activity, the regions showing RA activity (shown in light blue overlapping an embryo
schematic) are roughly in the middle of the embryo with notable absence of signaling at the
most anterior and posterior ends of the embryo.
The requirement for RA in patterning all three germ layers leads to a key question in
anterior-posterior patterning of the endoderm. The overlying lateral plate mesoderm helps to define the
anterior-posterior pattern of the underlying endoderm [77,84] and although boundaries of gene
expression domains within the overlying lateral plate mesoderm are quite broad, they are partially
defined by RA [85,86]. However, the boundaries for the developing endodermal organs are
considerably smaller. One of the lateral plate mesoderm domains can be outlined by the expression of
foxF1, a forkhead family transcription factor whose expression domain overlies the dorso-anterior
endoderm [85,87]. The foxF1 expression domain can be shifted by altering RA signaling [85] and loss
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of foxF1 results in gut tube defects [87]. The defects, in addition to patterning, are mainly attributed to
the inability of the lateral plate mesoderm to adequately surround the developing endoderm. Thus to
generate the endodermal pattern, it is difficult to determine whether RA acts directly on the endoderm,
indirectly on the overlying mesoderm, or a combination of both. Although studies of lung development
support the latter [88], further investigation is needed with other endodermal organs to fully
appreciate the roles for RA signaling in individual germ layers that are needed to generate the
anterior-posterior pattern.
5. Role of Retinoic acid in Individual Organ Systems
5.1. Retinoic Acid and the Thyroid
The thyroid is the most anterior of the endodermal organs and RA does not appear to play a role in
its specification and differentiation. Reporters of RA activity do not show activity in the early mouse
thyroid [88] and in the chick it develops in the absence of retinoic acid [11]. In Xenopus, the presence
of RA actually causes the thyroid primordium to acquire characteristics of the lung, including the
expression of surfactant protein genes [80]. That in both chick and Xenopus the expression of Hex in
the thyroid is suppressed by the presence of RA, while expression in the liver is unchanged, would
suggest that RA is suppressing the very early steps in thyroid differentiation [11,80].
5.2. Retinoic Acid and the Anterior Foregut
The dependency on RA signaling becomes apparent as one moves posterior along the gut tube from
the thyroid. The remainder of the foregut, immediately posterior to the thyroid, is a site of active RA
signaling [89], and mice that lack Raldh2 die at about E10.5, prior to significant development of the
foregut [42]. However, if the mothers are provided with exogenous RA, the lethality is partially rescued
allowing for analysis of later foregut development. With only partial rescue or timed use of
RA antagonists, such that lung development is initiated, the foregut and trachea are not well
separated [89–91]. These results would indicate that RA is essential for maturation or morphogenesis
in the anterior foregut.
5.3. Retinoic Acid and the Pharynx
Pharyngeal pouches are a complex tissue that is formed from components of all three germ layers
and through interactions with the adjacent migrating neural crest. The pharyngeal endoderm, which
contributes to the pouches arises between the thyroid and lung [92], is important in craniofacial
development and is disrupted by either excess or reduced RA signaling [93]. Reduced signaling causes
a decrease in the number of pharyngeal pouches [94–96] due to a loss of branchial arches 3 through
6 [97]. In contrast, excess RA causes defects in the first two branchial arches [98]. Given the complex
development of this region, it has been difficult to determine which cell types in the pharynx require
RA. Experiments in a variety of animals have demonstrated that there are also roles for RA in
patterning the migrating neural crest and signaling affects its development [94–96,98]. However, timed
treatments with antagonists that do not disrupt the neural crest still cause pharyngeal arch defects and
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direct changes in the expression of key endoderm genes, which would suggest that the endoderm is a
key target of RA signaling [99].
Interactions between the neural crest and the pharyngeal endoderm result in a series of pouches that
give rise to specialized endocrine glands including the thyroid (discussed above), parathyroid, thymus
and the ultimobranchial body [100]. Which of these glands form, and which pharyngeal arch they are
associated with, varies between phylogenetic groups and given that altering RA signaling alters arch
patterning, it is not surprising that RA is related to these endocrine glands. Exogenous RA causes
defects in the development of the thymus [101] and loss of retinoic acid signaling results in loss of
both the parathyroid and thymus in mice [94].
Specification of the pharyngeal endoderm is not affected in zebrafish lacking RA, but the
morphogenesis of the pouches is altered in a time dependent manner [95] and a point mutation in the
zebrafish Aldh1a2 gene called neckless results in a loss of pouch 3 and 4 [102]. This disruption in
morphogenesis could be due to the altered migration of cells or segmentation of the pouches, with
reduced segmentation causing the reduction in pouch number [95].
An attractive mechanism for how RA alters pharyngeal endoderm is by altering the expression
pattern of the Hox genes. This family of transcription factors are essential for anterior posterior
patterning in all germ layers and a specific role in the pharyngeal endoderm is well established [103].
RA is able to shift the expression pattern of Hox genes in the pharyngeal mesoderm [11,94,98,99] and
thus it is likely that RA can also regulate Hox expression in the pharyngeal endoderm [101]. Hox genes
are known to vary in response to different concentrations of RA in many tissues and reporter
assays for RA activity suggest that such a gradient of RA signaling exists in the pharyngeal
endoderm [53,99,104].
Tbx1 is an important transcription factor that is at least partially responsible for a human hereditary
defect called DiGeorge syndrome that has characteristic defects in branchial arch morphogenesis.
Aldh1a2 and Tbx1 genetically interact suggesting that elements of the RA signaling pathway could
modify the DiGeorge syndrome phenotype [105]. Interestingly, in zebrafish and Xenopus the
patterning within the pharynx may be altered, but the overall length of the region appears to remain
unchanged when compared to the position of the lung and thyroid [80,95]. In amphioxus, the posterior
limit of the pharynx is regulated by RA [106]. This apparent difference in a role for defining pharyngeal
boundaries could be due either to evolutionary change during vertebrate evolution or simply differing
techniques or timing in the interference of RA signaling.
5.4. Retinoic Acid and the Lung
Retinoic acid is critical to the development of the lung and in mice lacking Aldh1a2, lungs are
absent [91,107]. This requirement for RA is evolutionarily conserved [11,80]. Initial specification
appears to be unaffected based on the presence of Nkx2.1 expression in mice with blocked RA
signaling, but without RA the lung primordium does not enlarge or express markers of
differentiation [108]. After initial specification, RA is necessary for the integration of multiple signaling
pathways needed for lung development. In the early endoderm, expression of Dickopf, a secreted
inhibitor of the Wingless (Wnt) pathway, is suppressed by RA signaling and this suppression allows for
local activation of Wnt signaling. Wnt signaling in turn promotes a critical Fgf10 signal from the
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adjacent mesoderm, which is necessary for the formation and growth of the lung bud [88]. At the same
time, RA is necessary for the suppression of Tgfβ signaling which facilitates Fgf10 signaling [109].
Simultaneous suppression of Tgfβ signaling with antagonists while activating Wnt signaling will
rescue lung bud formation in RA-deficient embryos [88]. That the same is true using beads soaked in
Fgf [110] would strongly implicate this signaling network in promoting lung bud growth. Once the bud
has grown, reduced RA signaling is needed for proper branching morphogenesis [111]. Given the tight
regulation of Fgf signaling that is required for branching morphogenesis and the ability of RA to alter
Fgf signaling, the observations that excess RA can disrupt branching is not surprising.
Several studies have noted that there are differences in the requirement for RA between the left and
right lobe of the lung. When there is maternal supplementation of RA to developing embryos lacking
Aldh1a2, lung buds outgrowth occurs, but the right side develops much better than the left. In embryos
with deletion of multiple RARs [91], or in embryos from mothers on a vitamin A deficient diet [112],
lung development is poor. In these animals there is an observable lung, but left lobe is lost and the
right is usually hypoplastic. It is still not clear what the basis is for these phenotypes, but the promotion
of asymmetric Fgf10 expression by RA [88] is potentially involved [111,113]. RA is also known to
alter left-right coordination in the somites [114,115], but it is not clear as to whether or not these
alterations to left-right patterning are linked. Recently, morpholino knockdown of Rargb in zebrafish
has shown that that the RA receptor is necessary for liver and pancreas asymmetries as well as heart
looping, another indicator of disrupted left-right asymmetry [116] and similar organ asymmetries occur
in Xenopus gut morphogenesis [117]. How these asymmetries are manifested will be critical in
understanding if these defects are at the level of individual organ morphogenesis or the result of
something more general.
The role of RA in lung is clearly relevant to humans because mutations in the RA pathway are
associated with syndromes linked to disrupted lung development, including PAGOD syndrome [118]
and Matthew Wood syndrome that results from mutations in STRA6 [119]. Later roles for RA in lung
maturation have also recently been demonstrated. Mice with dietary deficiencies in RA have increased
smooth muscle differentiation in the fetal lung and this has implications for adult health in the mice.
The RA deficient mice are hyper responsive to airway stimulation and the aberrant response persists
regardless of the vitamin A status of the adult [120]. Thus, RA deficiencies in fetal life pose a
significant health issue in the developing world, and have lifelong implications in terms of lung health
in adults.
5.5. Retinoic Acid and the Pancreas
Retinoic acid is essential for normal pancreatic development. In mammalian embryos lacking
Aldh1a2, there are significant defects in the pancreas [53,121]. The requirement is also evolutionarily
conserved. Studies on avian embryos revealed that signals from the lateral plate mesoderm drive
endodermal cells to express Pdx1 and thus take on a pancreatic fate [77]. Evidence suggests that RA
may be that mesodermal signal required for initiation of Pdx1 expression [9,122]. Examination of
mouse embryos carrying the RA-reporter transgene demonstrated that the pancreas is normally
exposed to RA generated in the surrounding splanchnic lateral plate mesoderm [53]. In the mouse,
expression of a dominant negative RAR in early pancreatic progenitors results in pancreatic agenesis
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also suggesting that the endoderm is a direct target of the RA signal promoting pancreatic
development [123]. However, in chick explants, the effect of RA on promoting pancreas requires
mesoderm suggesting that the RA is also acting on the mesoderm to drive pancreas
differentiation [77]. Excess RA is able to drive an anterior expansion of the Pdx1 expression domain in
zebrafish demonstrating that it is both necessary and sufficient for pancreas formation [124].
The pancreas is formed from two distinct buds, one dorsal and one ventral (Figure 1). In most
organisms, the RA is required for development of the dorsal pancreas but that requirement does not
extend to the ventral bud. In the mouse, the dorsal bud is lost in the mouse whereas the ventral bud is
less affected. Treatment of Xenopus embryos with a retinoic acid receptor antagonist also shows a loss
of the dorsal bud with no clear effect on the ventral bud [10,125]. Zebrafish embryos deficient in RA
lack Pdx1 expression and consequently fail to develop any recognizable pancreas [9,126]. In the chick
embryo, there is also loss of the both pancreatic buds with the loss of RA signaling [11]. In Xenopus,
the dorsal bud develops into the endocrine pancreas whereas the ventral bud forms the
exocrine pancreas.
Cyp26 expression limits the size of the pancreas and that expression is regulated by retinoic acid.
This provides a model where retinoic acid is necessary for formation of the pancreas and also creates a
negative feedback loop that regulates pancreas size [124]. Size regulation by RA in the mouse
pancreas, in particular the β-cell and α-cell mass, continues in the adult because vitamin A deficiency
results in reduced mass that is subsequently restored when normal vitamin A levels are restored [127]
5.6. Retinoic Acid and the Liver
Retinoic acid is an important regulator of liver function and is essential for retinoic acid metabolism
in the adult [128] and thus it is perhaps surprising that is apparently not essential for specification of
the liver in model organisms, with the exception of zebrafish. Mice lacking Raldh2 still express key
early liver transcription factors including Prox1 and Hhex in the region of the embryo destined to form
liver [53]. Xenopus and chick are similar to mammals as liver specification occurs in embryos lacking RA
activity [10,125]. Exogenous RA can suppress Hhex expression in the chick and Xenopus thyroid [11,80]
and is also required for suppression of Hhex in the foregut endoderm between the thyroid and
liver [11] but Hhex expression is not altered in the developing liver. In contrast, zebrafish embryos do
require RA for liver specification and exogenous RA can cause ectopic liver formation [9]. Additional
evidence for a role for RA in formation of the liver in zebrafish come from the suppression of Rbp4, a
transporter of retinol in mammals, using splice-blocking morpholinos. Knockdown of Rbp4 mRNA
results in duplicated liver buds in the embryos. As Rbp4 is expressed in the yolk syncytial layer and not the
endoderm, it is thought that this could be due to migratory changes in liver precursors [129]. Further
evidence that Rbp4 is altering RA signaling in the Rbp4 morphants is needed before a complete
understanding of this phenotype. In mouse and chick embryos lacking RA signaling, the liver is smaller
suggesting that RA does promote liver growth in later development [11,89] but liver specification does
not require RA in those embryos.
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5.7. Retinoic Acid and the Stomach
RA signaling is active in the endoderm that will give rise to the stomach [89]. In mice lacking
Aldh1a2, the stomach does not form properly with the posterior stomach that gives rise to the glandular
portion of the stomach being absent [89]. Those mice also have reduced expression of Hox genes that
are essential for regionally subdividing the Cdx expression domain into specific hindgut regions [130].
Similar to the lung, expression of Fgf10 in the stomach primordium requires RA signaling [89] which
nicely corresponds to the requirement for Fgf10 signaling in the development of the glandular
stomach [131].
5.8. Retinoic acid and Posterior Endoderm
In comparison to the more anterior regions of the gut, less is known about the relationship between
RA and the patterning of the hindgut. The lack of information is largely due to the lethality of embryos
lacking RA signaling prior to complete patterning of the posterior regions of the gut. In addition, there
are relatively few markers of early hindgut that could be used to understand early patterning events.
Addition of exogenous RA clearly disrupts the morphogenesis of this region with lack of looping and
rotation [132,133] and differing levels of RA may even be important in the evolution of novel gut
morphologies [134]. However, loss of RA signaling experiments in the hindgut, that can circumvent
the earlier requirements for RA in other tissues, are necessary for an in depth understanding of the role
of RA in this region.
Cdx genes are early markers of posterior endoderm and are essential for defining boundaries of the
different gut domains including the intestine and duodenum [13]. It is clear that a variety of signaling
pathways including sonic hedgehog, Fgf and Wnt are needed for Cdx expression and retinoic acid also
plays a role in defining the Cdx expression [11]. Expression of dominant-negative RARs in the chick
endoderm blocks Cdx expression suggesting that there is a direct requirement for RA signaling within
the endoderm to maintain expression although treatment with RA antagonists does not always eliminate
Cdx expression and addition of exogenous RA is not able to change the anterior boundary of Cdx
expression [11]. Subdivision of the Cdx expression domain into different regions such as the large and
small intestine correspond to expression of different members of the Hox gene cluster and it is likely that
these are essential for defining the different fates as mutations in different Hox genes do cause gut
malformations [130]. Given the essential role for RA in directly regulating the Hox gene
cluster [104,135], it would appear likely that subdivision of the hindgut would be regulated, at least in
part, by RA.
Although differentiation of the colon is apparently normal in mice lacking retinoic acid production,
it is still an important component of colon physiology. In mice lacking Aldh1a1, Aldh1a2, and
Aldh1a3, there is reduced density of enteric neurons and this reduced innervation results in reduced
motility of the colon [136,137]. Interestingly, different deletion combinations of the retinaldehyde
dehydrogenases had varying effects on different subtypes of enteric neurons suggesting that
understanding the exact roles for RA in gut innervation will be complex. Direct effects on differentiation
of the intestine have been observed in zebrafish embryos that lack either rdh1l (retinol dehydrogenase)
or the adenomatous polyposis coli (APC) tumor suppressor gene. The requirement for both is
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explained by the observation that APC is required for the expression of rdh1l and the loss of markers of
intestinal differentiation seen when either are suppressed can be rescued by exogenous RA
treatment [138]. Another retinol dehydrogenase, rdh1, is also required for intestinal differentiation in
zebrafish but its requirement is restricted to the anterior gut and this corresponds to its graded expression
pattern with highest levels of expression in the anterior gut [139]. The link to the Hox genes is
reinforced by this study as over expression of hoxc8, normally regulated by RA, was able to partially
rescue the differentiation of the intestine.
The prostate gland is an out pouching of the posterior endoderm and RA is both necessary and
sufficient for the formation of prostatic buds [140]. Fgf10 is also essential for budding of the
prostate [141]. This raises the possibility of an RA-Fgf10 axis for bud outgrowth as has been
demonstrated for the lung.
6. Definitive Endoderm vs. the Extraembryonic Endoderm Lineage
It has been nearly 40 years since investigators recognized that mouse teratocarcinoma cells could be
chemically differentiated into the extraembryonic endoderm (ExEn) lineage [142], recapitulating that
which develops in the mouse embryo at E4.5 just before implantation (Figure 3) [143,144]. Chemical
induced differentiation has since been reported for human embryonal carcinoma (EC) cells [145] and
for human and mouse embryonic stem (ES) cells [146–150]. One of these specific chemicals is RA,
which is indispensable for embryonic development [2,151] and depending on the context is considered
an inducer, a morphogen and/or a teratogen to developing embryos. In vitro models, including the F9
teratocarcinoma cell line have been instrumental in our understanding of retinoid signaling [152], and
it is well known that when F9 cells are treated with RA, they differentiate as primitive extraembryonic
endoderm (PrE) [31]. Moreover, RA in combination with agents like dibutyryl cAMP (db-cAMP),
parathyroid hormone (PTH) or PTH-related peptide (PTHrP), to increase protein kinase A (PKA) activity,
induce PrE cells to differentiate into parietal endoderm (PE) [142,153–156]. Interestingly, whereas RA
commits cells to form PrE, in other cases when RA is not used, the commitment is transient when the
inducing signal is removed [30,157]. Nevertheless, RA treatment leading to differentiation of the
extraembryonic endoderm lineage is accompanied by the concomitant increase in tissue plasminogen
activator (tPA) [158] and decrease in the levels of stage-specific embryonic antigen [159], both
commonly linked to the loss of pluripotency. Growing F9 cells in suspension and in the presence of
RA also allows for the differentiation of visceral endoderm (VE), which is morphologically and
biochemically distinct from PE as these cells synthesize alpha-fetoprotein [144,160,161].
In addition to the changes in gene expression noted above, EC and ES cells have shed considerable
light on the fact that ExEn differentiation is accompanied by significant changes in gene expression,
and this has been reported in several gene-profiling studies [152,162–172], including both positive and
negative regulation imposed on the RA receptors themselves [173,174]. Although assembling these
changes in gene regulation into a hierarchy or network has until recent been problematic, integrative
genomics have nevertheless revealed the diversity of distinct regulatory programs involved in RA
signaling during F9 cell differentiation [175]. This diversity is even more complex given the epigenetic
regulation that was identified as playing a role in VE differentiation [176]. A recent review has since
highlighted the role RA plays in epigenetic mechanisms of stem cell differentiation [177]. Finally, and
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in addition to these RA-induced epi/genomic changes, there is evidence that cell-cell and cell-matrix
interactions are also involved in the specification of PE and VE [178], and this is influenced by noncanonical Wnt signaling [179].

Figure 3. Formation of extraembryonic endoderm in mouse development. Cells of the
inner cell mass (yellow), expressing Oct4, Gata6 and Nanog, and those of the
trophectoderm (grey), expressing Cdx2, are the primary cell populations present prior to
implantation of the blastocyst. A second round of segregation leads to cells of the epiblast
(red), which continue to express Nanog and will eventually give rise to the three germ layers
of the embryo proper, and those committed towards the extraembryonic endoderm lineage
that express Gata4 and 6, Sox7 and 17, Dab2 and FoxA2. Soon after, cells of the primitive
extraembryonic endoderm that undergo an epithelial-to-mesenchymal transition, migrate on
a basement membrane along the trophectoderm and develop as parietal extraembryonic
endoderm (green). Primitive endoderm cells still associated with the basement membrane
of the epiblast acquire a cuboidal morphology, and develop into visceral extraembryonic
endoderm (purple); some of which contributes to definitive endoderm.
Deciphering these regulatory programs involved in ExEn differentiation has revealed that while
similarities exist between the differentiation of mouse and human EC cell lines [180], differences even
between mammalian species preclude formalizing generalizations; the same is also true for ES cells
between different species [181,182]. Nevertheless, the host of profiling studies mentioned above
documenting the ability of RA to regulate the expression of a plethora of genes in F9 cells has been
complemented by several detailed studies on specific genes including Rex-1 [183], laminin B1 [184],
Mct8 [185], Disabled-2 [186,187] and PTH/PTHrP [188], to name a few. In the case of the latter, and as
described above, RA exposure followed by subsequent treatment of PTH or PTHrP is sufficient to
induce F9 cells to form PE [189–191]. PTHrP bound to its G-protein coupled PTH/PTHrP receptor
(GPCR) stimulates adenylyl cyclase to increase cAMP levels [192]. These and other studies have
shown that while RA induced differentiation is accompanied by an increase in Ras/ERK activity leading
to PrE, this activity must be attenuated by increased PKA signaling in order for cells to develop into
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PE [189,193,194]. Evidence from in vivo expression and localization studies and from work with ES
cells support this model [195–198]. PTHrP activation of its GPCR also leads to the up-regulation of an
immediate early target gene encoding the transcriptional repressor Snail1 [199], which accumulates in
response to the inhibition of Glycogen Synthase Kinase-3 and serves to negatively regulate Cdh1, which
encodes E-cadherin [200]. This signaling axis has expanded to include other players and it is now generally
accepted that extensive crosstalk between disparate signaling pathways are necessary for patterning
ExEn. One of these pathways involves heterotrimeric G-protein signaling activated by RA in F9
cells [201,202] and in P19 cells [203–207]. Other gene networks induced by RA include, but
are not limited to thyroid hormone signaling involving monocarboxylate transporters [185] and to
the positive and negative regulation imparted on the non-canonical and canonical Wnt
pathways [30,179,201,208–213]; the latter also linked to Snail1 stabilization.
At the center of all of these signaling pathways involved in the differentiation of the ExEn lineage
are transcription factors and transcriptional regulators, some which are regulated directly or indirectly
by RA. This is an ever-increasing pool that includes GATA binding proteins 4 and 6 [214,215], the
Sry-related HMG-box transcription factor Sox7 and Sox17 [216–220], transcription factor 2,
Tcf2 (vHnf-1b) [221], FoxA1 (Hnf-3a) [222], FoxA2 (Hnf-3b) [223], Hnf-4 [224] and
Disabled-2 [225,226]. These and many more have been identified and validated by microarray analysis of
ExEn isolated from embryos [227]. As with the complexity of the epigenetics introduced earlier, teasing
apart the intricacies of this transcriptional regulation is convoluted by the fact that these transcription
factors often regulate the expression of each other, as in the case of Sox7 up-regulating Gata4 and 6
expression [220], Gata6 activating Gata4 [228], the feed-back and feed-forward loops between
Disabled-2, Gata4 and Gata6 [226], Tcf2 (vHnf-1b) and Gata6 linked to Hnf-4a1, Hnf1a and Hnf3g
(FoxA3) expression [221,228], and finally Gata6 inducing FoxA2 [229].
Many of the pathways and participating players noted above that induce naïve cells to form the
ExEn lineage are also known to be involved in patterning the definitive endoderm [13,23,230,231].
Towards that end, recent advances with eXtra-embryonic ENdoderm (XEN) cells [232,233], which can
be induced from ES cells by RA treatment or by overexpressing Gata6 [29,234,235], and with two
other ExEn cell lines, END2 and PYS2 [236], are slowly unraveling the signals that not only pattern
extraembryonic and definitive endoderms, but also mesodermal and ectodermal tissues. Epigenetic
changes known to regulate the differentiation of ES cells, noted earlier, also contribute to defining the
fate of XEN cells, which has a DNA methylation signature that differs from ES, epiblast or trophoblast
stem cells [237]. Even within the same XEN cells, the balance and crosstalk between pathways play a
critical role in dictating the lineage that will differentiate. This is seen in rat XEN cells that form VE
when canonical Wnt signaling is activated, but develop into PE following the activation of the PTHrP
pathway [181]. Thus, although much remains to be learned, studying how the ExEn lineage is
patterned using in vitro models has merit as it has provided the basis for potential therapeutic
applications of differentiating ExEn into definitive embryonic endoderm [182]. Although RA per se
may not be necessary in these processes, the importance of retinoid signaling as described above, again
in combination with several other signaling pathways, is nevertheless crucial in patterning and shaping
definitive endodermal structures [238].
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7. Future Directions
Although we now know that retinoic acid is absolutely required for the development of most
endodermal organs, there are several questions that need to be addressed before we fully understand
the details of its role in the endodermal development. Given the ability of retinoic acid to signal across
cells, understanding the site of action(s) for retinoic acid remains difficult. For example, patterning of
the endoderm is in part controlled by the overlying lateral plate mesoderm [77,84] and retinoic acid
can act on both tissues [53,123]. Evidence from reporters of retinoic acid signaling suggests that it will
be a combination of both. As more sophisticated genetic models are developed, where Aldh1a2 or the
RA receptors are eliminated in specific tissues or times, the relative contributions of mesoderm and
endoderm RA signaling and responses can be addressed. Such models will also be useful in delineating
the roles of RA at different time periods during development. For example, it is clear that RA is needed
for precisely positioning the lung along the anterior-posterior axis, for lung bud outgrowth, branching
morphogenesis and subsequent maturation of the functioning lung. To what degree the later events are
due to defects in an early process that requires RA signaling, or are later, independent RA signaling
events can be partially worked out with the careful use of inhibitors but the definitive work with
conditional knockout animals should be able to tease out different temporal requirements for RA
signaling. This information is likely critical for better differentiation protocols used to drive stem cells
into specific endodermal cell types. At present, RA is a key ingredient in most protocols used to drive
endoderm development [239,240] and the RA is present over multiple differentiation steps. It is
possible that more regulated timing of the RA signal is necessary for further optimization of
differentiation protocols and better understanding of the normal development may provide rationales
for making those changes.
Retinoic acid does not act alone in regulating tissue differentiation and growth but in most cases,
our knowledge of the relationship between RA signaling and other pathways remains rudimentary.
Interactions between RA signaling and other signaling pathways have been well detailed in the
lung [88] and in the development of the extraembryonic endoderm [201,211] but it remains likely that
even our understanding of those interactions is limited. It has been suggested that the specificity for
RA signaling comes from its role in regulating local signaling networks rather than a gradient of retinoic
acid activating different targets at different concentrations [88] and identifying those local networks
will be important for a clear understanding of specific roles in individual tissues. Interestingly, one of
the best documented interactions is the role of retinoic acid is in regulating Fgf10 expression in the
lung [88] yet this interaction appears to be also linked with the stomach [131] and some non-endoderm
derived tissues [241,242]. This RA-Fgf10 interaction may represent a module for expansion of the
tissue rather than specification and is thus used for several organ systems independently.
Our understanding of the transcriptional targets of RA signaling is also limited. The advent of
chromatin immunoprecipitation (ChIP) to identify targets has begun [69,70] but in the case of the RA
receptors, there are clear difficulties that must be overcome. For most targets, the RA receptors will be
present on the promoter regardless of whether that promoter is transcriptionally active or not and thus
interpreting the information will require additional epigenetic (ChIP) data at those sites to determine the
likely transcriptional status associated with specific RAREs. Another technical issue is obtaining the
starting material from small, localized populations of endodermal organ precursors. This represents a
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significant challenge but would be necessary to determine the specificity of the development program
within those early organ systems. However, these are technical challenges that future scientists should be
able to overcome and the information will provide important new data in our understanding of this
fascinating signaling system and its role in endodermal development.
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